183 related articles for article (PubMed ID: 32270874)
21. Replication and Genetic Risk Score Analysis for Pancreatic Cancer in a Diverse Multiethnic Population.
Bogumil D; Conti DV; Sheng X; Xia L; Shu XO; Pandol SJ; Blot WJ; Zheng W; Le Marchand L; Haiman CA; Setiawan VW
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2686-2692. PubMed ID: 32958499
[TBL] [Abstract][Full Text] [Related]
22. Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients.
Rizzato C; Campa D; Talar-Wojnarowska R; Halloran C; Kupcinskas J; Butturini G; Mohelníková-Duchoňová B; Sperti C; Tjaden C; Ghaneh P; Hackert T; Funel N; Giese N; Tavano F; Pezzilli R; Pedata M; Pasquali C; Gazouli M; Mambrini A; Souček P; di Sebastiano P; Capurso G; Cantore M; Oliverius M; Offringa R; Małecka-Panas E; Strobel O; Scarpa A; Canzian F
Carcinogenesis; 2016 Oct; 37(10):957-64. PubMed ID: 27497070
[TBL] [Abstract][Full Text] [Related]
23. Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations.
Campa D; Rizzato C; Bauer AS; Werner J; Capurso G; Costello E; Talar-Wojnarowska R; Jamroziak K; Pezzilli R; Gazouli M; Khaw KT; Key TJ; Bambi F; Mohelnikova-Duchonova B; Heller A; Landi S; Vodickova L; Theodoropoulos G; Bugert P; Vodicka P; Hoheisel JD; Delle Fave G; Neoptolemos JP; Soucek P; Büchler MW; Giese N; Canzian F
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):320-3. PubMed ID: 23250936
[TBL] [Abstract][Full Text] [Related]
24. A pooled genome-wide association study identifies pancreatic cancer susceptibility loci on chromosome 19p12 and 19p13.3 in the full-Jewish population.
Streicher SA; Klein AP; Olson SH; Kurtz RC; Amundadottir LT; DeWan AT; Zhao H; Risch HA
Hum Genet; 2021 Feb; 140(2):309-319. PubMed ID: 32671597
[TBL] [Abstract][Full Text] [Related]
25. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
[TBL] [Abstract][Full Text] [Related]
26. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.
Campa D; Pastore M; Gentiluomo M; Talar-Wojnarowska R; Kupcinskas J; Malecka-Panas E; Neoptolemos JP; Niesen W; Vodicka P; Delle Fave G; Bueno-de-Mesquita HB; Gazouli M; Pacetti P; Di Leo M; Ito H; Klüter H; Soucek P; Corbo V; Yamao K; Hosono S; Kaaks R; Vashist Y; Gioffreda D; Strobel O; Shimizu Y; Dijk F; Andriulli A; Ivanauskas A; Bugert P; Tavano F; Vodickova L; Zambon CF; Lovecek M; Landi S; Key TJ; Boggi U; Pezzilli R; Jamroziak K; Mohelnikova-Duchonova B; Mambrini A; Bambi F; Busch O; Pazienza V; Valente R; Theodoropoulos GE; Hackert T; Capurso G; Cavestro GM; Pasquali C; Basso D; Sperti C; Matsuo K; Büchler M; Khaw KT; Izbicki J; Costello E; Katzke V; Michalski C; Stepien A; Rizzato C; Canzian F
Oncotarget; 2016 Aug; 7(35):57011-57020. PubMed ID: 27486979
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms in inflammatory genes and pancreatic cancer risk: a two-phase study on more than 14 000 individuals.
Gentiluomo M; Peduzzi G; Lu Y; Campa D; Canzian F
Mutagenesis; 2019 Dec; 34(5-6):395-401. PubMed ID: 31748817
[TBL] [Abstract][Full Text] [Related]
28. Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction.
Galeotti AA; Gentiluomo M; Rizzato C; Obazee O; Neoptolemos JP; Pasquali C; Nentwich M; Cavestro GM; Pezzilli R; Greenhalf W; Holleczek B; Schroeder C; Schöttker B; Ivanauskas A; Ginocchi L; Key TJ; Hegyi P; Archibugi L; Darvasi E; Basso D; Sperti C; Bijlsma MF; Palmieri O; Hlavac V; Talar-Wojnarowska R; Mohelnikova-Duchonova B; Hackert T; Vashist Y; Strouhal O; van Laarhoven H; Tavano F; Lovecek M; Dervenis C; Izbéki F; Padoan A; Małecka-Panas E; Maiello E; Vanella G; Capurso G; Izbicki JR; Theodoropoulos GE; Jamroziak K; Katzke V; Kaaks R; Mambrini A; Papanikolaou IS; Szmola R; Szentesi A; Kupcinskas J; Bursi S; Costello E; Boggi U; Milanetto AC; Landi S; Gazouli M; Vodickova L; Soucek P; Gioffreda D; Gemignani F; Brenner H; Strobel O; Büchler M; Vodicka P; Paiella S; Canzian F; Campa D
J Med Genet; 2021 Jun; 58(6):369-377. PubMed ID: 32591343
[TBL] [Abstract][Full Text] [Related]
29. A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma.
Giaccherini M; Gori L; Gentiluomo M; Farinella R; Cervena K; Skieceviciene J; Dijk F; Capurso G; Vezakis A; Archibugi L; Chammas R; Hussein T; Tavano F; Hegyi P; Lovecek M; Izbicki JR; Brenner H; Mohelnikova-Duchonova B; Dell'Anna G; Kupcinskas J; Ermini S; Aoki MN; Neoptolemos JP; Gazouli M; Pasquali C; Pezzilli R; Talar-Wojnarowska R; Oliverius M; Al-Saeedi M; Lucchesi M; Furbetta N; Carrara S; van Eijck CHJ; Maleckas A; Milanetto AC; Lawlor RT; Schöttker B; Boggi U; Morelli L; Ginocchi L; Ponz de Leon Pisani R; Sperti C; Zerbi A; Arcidiacono PG; Uzunoglu FG; Bunduc S; Holleczek B; Gioffreda D; Małecka-Wojciesko E; Kiudelis M; Szentesi A; van Laarhoven HWM; Soucek P; Götz M; Erőss B; Cavestro GM; Basso D; Perri F; Landi S; Canzian F; Campa D
Carcinogenesis; 2023 Dec; 44(8-9):642-649. PubMed ID: 37670727
[TBL] [Abstract][Full Text] [Related]
30. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility.
Campa D; Rizzato C; Stolzenberg-Solomon R; Pacetti P; Vodicka P; Cleary SP; Capurso G; Bueno-de-Mesquita HB; Werner J; Gazouli M; Butterbach K; Ivanauskas A; Giese N; Petersen GM; Fogar P; Wang Z; Bassi C; Ryska M; Theodoropoulos GE; Kooperberg C; Li D; Greenhalf W; Pasquali C; Hackert T; Fuchs CS; Mohelnikova-Duchonova B; Sperti C; Funel N; Dieffenbach AK; Wareham NJ; Buring J; Holcátová I; Costello E; Zambon CF; Kupcinskas J; Risch HA; Kraft P; Bracci PM; Pezzilli R; Olson SH; Sesso HD; Hartge P; Strobel O; Małecka-Panas E; Visvanathan K; Arslan AA; Pedrazzoli S; Souček P; Gioffreda D; Key TJ; Talar-Wojnarowska R; Scarpa A; Mambrini A; Jacobs EJ; Jamroziak K; Klein A; Tavano F; Bambi F; Landi S; Austin MA; Vodickova L; Brenner H; Chanock SJ; Delle Fave G; Piepoli A; Cantore M; Zheng W; Wolpin BM; Amundadottir LT; Canzian F
Int J Cancer; 2015 Nov; 137(9):2175-83. PubMed ID: 25940397
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide "pleiotropy scan" identifies HNF1A region as a novel pancreatic cancer susceptibility locus.
Pierce BL; Ahsan H
Cancer Res; 2011 Jul; 71(13):4352-8. PubMed ID: 21498636
[TBL] [Abstract][Full Text] [Related]
32. Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma.
Obazee O; Archibugi L; Andriulli A; Soucek P; Małecka-Panas E; Ivanauskas A; Johnson T; Gazouli M; Pausch T; Lawlor RT; Cavestro GM; Milanetto AC; Di Leo M; Pasquali C; Hegyi P; Szentesi A; Radu CE; Gheorghe C; Theodoropoulos GE; Bergmann F; Brenner H; Vodickova L; Katzke V; Campa D; Strobel O; Kaiser J; Pezzilli R; Federici F; Mohelnikova-Duchonova B; Boggi U; Lemstrova R; Johansen JS; Bojesen SE; Chen I; Jensen BV; Capurso G; Pazienza V; Dervenis C; Sperti C; Mambrini A; Hackert T; Kaaks R; Basso D; Talar-Wojnarowska R; Maiello E; Izbicki JR; Cuk K; Saum KU; Cantore M; Kupcinskas J; Palmieri O; Delle Fave G; Landi S; Salvia R; Fogar P; Vashist YK; Scarpa A; Vodicka P; Tjaden C; Iskierka-Jazdzewska E; Canzian F
Int J Cancer; 2019 Aug; 145(3):686-693. PubMed ID: 30672594
[TBL] [Abstract][Full Text] [Related]
33. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.
Rizzato C; Campa D; Pezzilli R; Soucek P; Greenhalf W; Capurso G; Talar-Wojnarowska R; Heller A; Jamroziak K; Khaw KT; Key TJ; Bambi F; Landi S; Mohelnikova-Duchonova B; Vodickova L; Büchler MW; Bugert P; Vodicka P; Neoptolemos JP; Werner J; Hoheisel JD; Bauer AS; Giese N; Canzian F
Oncol Rep; 2013 Apr; 29(4):1637-44. PubMed ID: 23403949
[TBL] [Abstract][Full Text] [Related]
34. Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients undergoing curative intent resection.
Zironda A; Zhang C; Day C; McWilliams RR; Starlinger P; Warner SG; Smoot RL; Cleary SP; Kendrick ML; Truty MJ; Thiels CA
HPB (Oxford); 2024 Jan; 26(1):145-153. PubMed ID: 37752029
[TBL] [Abstract][Full Text] [Related]
35. Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study.
Yamazaki H; Streicher SA; Wu L; Fukuhara S; Wagner R; Heni M; Grossman SR; Lenz HJ; Setiawan VW; Le Marchand L; Huang BZ
Cell Rep Med; 2024 Feb; 5(2):101391. PubMed ID: 38280379
[TBL] [Abstract][Full Text] [Related]
36. Early-onset pancreatic cancer: a population-based study using the SEER registry.
Ansari D; Althini C; Ohlsson H; Andersson R
Langenbecks Arch Surg; 2019 Aug; 404(5):565-571. PubMed ID: 31377855
[TBL] [Abstract][Full Text] [Related]
37. Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis.
McWilliams RR; Maisonneuve P; Bamlet WR; Petersen GM; Li D; Risch HA; Yu H; Fontham ET; Luckett B; Bosetti C; Negri E; La Vecchia C; Talamini R; Bueno de Mesquita HB; Bracci P; Gallinger S; Neale RE; Lowenfels AB
Pancreas; 2016 Feb; 45(2):311-6. PubMed ID: 26646264
[TBL] [Abstract][Full Text] [Related]
38. Elucidating the role of blood metabolites on pancreatic cancer risk using two-sample Mendelian randomization analysis.
Zhong H; Liu S; Zhu J; Xu TH; Yu H; Wu L
Int J Cancer; 2024 Mar; 154(5):852-862. PubMed ID: 37860916
[TBL] [Abstract][Full Text] [Related]
39. Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium.
Campa D; Rizzato C; Capurso G; Giese N; Funel N; Greenhalf W; Soucek P; Gazouli M; Pezzilli R; Pasquali C; Talar-Wojnarowska R; Cantore M; Andriulli A; Scarpa A; Jamroziak K; Delle Fave G; Costello E; Khaw KT; Heller A; Key TJ; Theodoropoulos G; Malecka-Panas E; Mambrini A; Bambi F; Landi S; Pedrazzoli S; Bassi C; Pacetti P; Piepoli A; Tavano F; di Sebastiano P; Vodickova L; Basso D; Plebani M; Fogar P; Büchler MW; Bugert P; Vodicka P; Boggi U; Neoptolemos JP; Werner J; Canzian F
Dig Liver Dis; 2013 Feb; 45(2):95-9. PubMed ID: 23206934
[TBL] [Abstract][Full Text] [Related]
40. His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk.
Ohnami S; Sato Y; Yoshimura K; Ohnami S; Sakamoto H; Aoki K; Ueno H; Ikeda M; Morizane C; Shimada K; Sakamoto Y; Esaki M; Saito I; Hirose H; Saito D; Sugimura H; Kosuge T; Okusaka T; Yoshida T
Gastroenterology; 2008 Aug; 135(2):477-88. PubMed ID: 18515090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
